Valuation: Progyny, Inc.

Market Cap 2.22B 1.98B 1.83B 1.66B 3.11B 211B 3.16B 22.07B 8.74B 111B 8.34B 8.16B 349B P/E 2026 *
22.5x
P/E 2027 * 19.2x
Enterprise Value 2.06B 1.84B 1.7B 1.54B 2.87B 195B 2.92B 20.4B 8.08B 102B 7.71B 7.55B 322B EV / Sales 2026 *
1.5x
EV / Sales 2027 * 1.23x
Free-Float
75.41%
Yield 2026 *
-
Yield 2027 * -
1 day-0.52%
1 week+7.86%
Current month+15.01%
1 month+12.16%
3 months-5.64%
6 months+63.95%
Current year+12.81%
1 week 26.75
Extreme 26.7501
29.24
1 month 24.33
Extreme 24.33
29.24
Current year 16.1
Extreme 16.1
33.06
1 year 16.1
Extreme 16.1
33.06
3 years 13.39
Extreme 13.39
42.08
5 years 13.39
Extreme 13.39
68.32
10 years 13.29
Extreme 13.29
68.32
Manager TitleAgeSince
Chief Executive Officer 58 01/01/2022
Director of Finance/CFO 60 15/09/2020
Chief Operating Officer 56 17/04/2025
Director TitleAgeSince
Chairman 66 01/01/2022
Director/Board Member 77 16/12/2016
Director/Board Member 58 01/01/2022
Date Insider Type Main position Quantity % Market Cap. Importance
10/14/26 A Tax

Chief Operating Officer

-3,438 0.0045%
9/23/26 A Sell

General Counsel

-3,903 0.0051%
9/17/26 A Tax

Executive/Senior Manager

-819 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
-0.52%+7.86%+48.56%-8.73% 2.22B
-1.62%+4.15%+15.99%-19.84% 375B
-1.20%+2.73%+27.05%-2.62% 95.05B
-2.83%+1.54%+0.62%+1.96% 81.11B
+0.26%+2.16%+44.89%-18.12% 50.68B
-1.50%+1.46%+104.22%-0.97% 34.66B
-3.46%+0.86%+29.91%-39.31% 10.89B
+19.50%+5.41%+26.82%+49.91% 9.6B
-2.75%+2.68%+43.75%+398.32% 2.44B
-4.39%-2.66%-53.38%+13.20% 1.67B
Average +0.15%+2.76%+28.84%+37.38% 66.36B
Weighted average by Cap. -1.29%+3.51%+22.93%-11.24%

Financials

2026 *2027 *
Net sales 1.37B 1.23B 1.13B 1.03B 1.92B 130B 1.95B 13.64B 5.4B 68.35B 5.16B 5.05B 215B 1.51B 1.35B 1.25B 1.13B 2.12B 144B 2.15B 15.03B 5.95B 75.29B 5.68B 5.56B 237B
Net income 107M 95.25M 87.99M 79.74M 149M 10.13B 152M 1.06B 419M 5.3B 400M 392M 16.72B 125M 112M 103M 93.42M 175M 11.86B 178M 1.24B 491M 6.22B 469M 459M 19.59B
Net Debt -168M -150M -138M -125M -234M -15.91B -238M -1.66B -659M -8.34B -629M -616M -26.29B -358M -320M -295M -268M -501M -33.98B -509M -3.55B -1.41B -17.8B -1.34B -1.31B -56.12B
Projected Income Statement - Annual - Progyny, Inc.
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
846
Date Price Change Volume
23/10/26 $28.97 -0.52% 565,859
22/10/26 $29.12 +2.39% 744,612
21/10/26 $28.44 -0.49% 712,709
20/10/26 $28.58 +2.66% 1,233,746
19/10/26 $27.84 +3.65% 782,040
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Progyny, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
28.97USD
Average target price
34.42USD
Spread / Average Target
+18.80%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Progyny, Inc.
  1. Stock Market
  2. Stocks
  3. PGNY Stock